Safety of a Single Dose (Participants Aged 9 Years and Older) or Two Doses Given 28 Days Apart (Participants Aged 6 Months to 8 Years) of the Shenzhen Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Trial Profile

Safety of a Single Dose (Participants Aged 9 Years and Older) or Two Doses Given 28 Days Apart (Participants Aged 6 Months to 8 Years) of the Shenzhen Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Apr 2018

At a glance

  • Drugs Influenza virus vaccines (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Apr 2018 Planned End Date changed from 8 Jan 2019 to 20 Feb 2019.
    • 10 Apr 2018 Planned primary completion date changed from 8 Jan 2019 to 20 Feb 2019.
    • 10 Apr 2018 Planned initiation date changed from 18 Sep 2018 to 31 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top